Abstract-Designing bug-free medical device software is challenging, especially in complex implantable devices that may be used in unanticipated contexts. Safety recalls of pacemakers and implantable cardioverter defibrillators due to firmware problems between 1990 and 2000 affected over 200,000 devices. This encompasses 41% of the devices recalled and continues to increase in frequency [1] . There is currently no formal methodology or open experimental platform to validate and verify the correct operation of medical device software. To this effect, a real-time Virtual Heart Model (VHM) has been developed to model the electrophysiological operation of the functioning (i.e. during normal sinus rhythm) and malfunctioning (i.e. during arrhythmia) heart. We present a methodology to construct a timedautomata model by extracting timing properties of the heart. The platform employs functional and formal interfaces for validation and verification of implantable cardiac devices. We demonstrate the VHM is capable of generating clinicallyrelevant response to intrinsic (i.e. premature stimuli) and external (i.e. artificial pacemaker) signals for a variety of common arrhythmias. By connecting the VHM with a pacemaker model, we are able to pace and synchronize the heart during the onset of irregular heart rhythms. The VHM has also been implemented on a hardware platform for closed-loop experimentation with existing and virtual medical devices. This integrated functional and formal device design approach has potential to help expedite medical device certification for safe operation.
I. . INTRODUCTION
The heart is one of the most fundamental and important natural real-time systems. The heart spontaneously generates electrical impulses which organize the sequence of muscle contractions during each heart beat. The underlying pattern and timing of these impulses determine the heart's rhythm and are the key to proper function. Derangements in this rhythm impair the heart's ability to pump blood. Thus, the heart's electrical timing, also known as its electrophysiological operation, is fundamental to proper cardiac function.
The use of implantable cardiac devices such as pacemakers and cardioverter-defibrillators has grown rapidly over the recent decades. In the 20-year period from 1985 to 2005, the US Food and Drug Administration's (FDA) Maude database records nearly 30,000 deaths and 600,000 injuries due to device failures [2] . There is currently no formal methodology or experimental platform to ensure the correct operation of medical device software. The FDA has expressed the need for rigorous real-time methodologies to validate and verify medical device software, as is currently done in the domains of avionics and industrial control automation [3] .
Medical devices are inherently Cyber-Physical Systems, where the control and computation within the device is tightly coupled with the sensing and actuation of the biological physical substrate (i.e. the heart). It is therefore essential to model the functioning of the device within the physical environment. The relation between the physical state and the device state is largely non-deterministic, interactive, and cannot be fully captured by computational models. The modeling of the physical substrate must therefore be restricted to specific cases. Hence, the validation and verification observations are only valid for those specific cases.
A. . Functional and Formal Modeling of the Heart
To address this need, a Virtual Heart Model (VHM) has been developed to emulate the heart's electrophysiological operation for common arrhythmias. The VHM provides both functional and formal interfaces for validation and verification of implantable cardiac devices, as shown in Fig. 1 . We present a methodology to extract timing properties of the heart and design a kernel using the timed automata approach [4] , as the timing of the heart's electrical system is fundamental to the cardiac function [5] . While several cellular-based heart models exist [6] , [7] , [8] , [9] , they are useful for simulation only and not for software verification. By simplifying the continuous system to event-based timed-automata, we are able to both simulate and verify system for specific cases of interest. The functional and formal interfaces of the VHM are derived from a common kernel. The kernel models the cardiac action potential, which is a principal phenomena of the heart's conduction system. This allows us to model the heart as a network of nodes, which are abstractions of localized electrical tissue. Conduction between nodes is modeled by paths with known propagation and timing behavior. The functional model emulates the behavior of the heart and is validated by comparing the behavior of the VHM to three common cases of normal and abnormal heart rhythm. The clinical relevance of the outputs from the model have been validated by an electrophysiologist. Validation of medical devices can then occur through closed-loop simulation and black-box testing.
B. . Closing the Loop with Medical Devices
After the VHM is validated, we are in the position to validate and verify medical devices in closed-loop operation with the VHM. We designed and validated the functional pacemaker model for the two most frequent arrhythmias. The formal model of the pacemaker was designed and verified within the context of the VHM using Simulink Design Verifier [10] . Following this, the VHM was implemented on a FPGA-based hardware platform and the pacemaker was implemented on a microcontrollerbased platform for closed-loop experimental evaluation.
C. . Organization of the paper
The primary contribution of this effort is the development of an integrated functional and formal device design approach. It has the potential to help expedite medical device certification for safer operation. In Section II, we describe the VHM and the method by which the timing parameters are extracted. Section III provides medical validation of the VHM. In Section IV, we introduce the pacemaker model and its closed-loop evaluation. Finally, Section V describes an FPGA implementation of the VHM along with the closed-loop hardware setup used for pacemaker validation.
II. . VHM PLATFORM

A. . The Cardiac Electrical System
In order to better understand the operation of the heart, we provide some background of its physiology. The human heart maintains blood circulation of the body by coordinated contraction of the atria and ventricles. Fig. 2(a) shows the essential elements of the electrical conduction system of the heart. The electrical signal originates from specialized tissue in the sinoatrial (SA) node, which serves as the primary pacemaker of the heart. This signal is conducted radially through both atria, causing them to contract. The signal then passes through the slow conducting AV node, allowing blood to empty out of the atria and fill the ventricles. The fast-conducting His-Purkinje system spreads the electricity through the ventricles, causing them to contract and force blood out of the heart [5] . This electrical system provides organized contraction of the heart muscle and optimizes hemodynamics. Abnormalities in the electrical signal generation and propagation can cause different types of arrhythmias like, tachyarrhythmias (abnormally fast heart rate) and bradyarrhythmias (abnormally slow heart rate). These require medical intervention in the form of medication, surgery, or an implantable device.
The electrical signal that passes through the heart is known as an action potential, shown in Fig. 3(a) . The action potential is triggered by a voltage spike from the action potential of its neighboring tissue or by an artificial pacing signal. The upstroke indicates the depolarization of the cell and the time when the muscle contracts. This is followed by the plateau, which allows the muscle to hold its contraction and fully eject blood. The down-stroke is repolarization, when the muscle relaxes and refills.
The total refractory period is the length of time from the first depolarization until the cell becomes ready for a second excitation. This can be divided into two time periods, effective refractory period (ERP) and relative refractory period (RRP). The cell cannot be activated by an electrical stimulus while in ERP, which acts as a blocking interval. While in RRP, the cell can be partially excited again, but this causes changes in the timing of the resultant action potential. The shape and timing of the action potential determines the conduction velocity and refractoriness of the heart. The duration of the plateau determines the duration of the ERP. The slope of depolarization determines the conduction velocity of the tissue.
The electrical activity of the heart can be monitored externally by an electrocardiogram (ECG) or internally by electrograms. The ECG is recorded from the skin of the torso and provides a global view of the electrical activities of the heart. The electrogram signal is recorded from electrodes on the inside surface of the heart. Electrograms are useful in diagnosing cardiac arrhythmias for their capability of localizing the source of activation [11] . Pacemakers and implantable cardioverter-defibirillators (ICD) record electrograms to diagnose arrhythmias and determine when therapy is necessary. 
B. . Timing Model of the VHM
Modeling individual cells in order to obtain a view of the entire heart is processor heavy and contains extraneous information for purposes of device testing. Instead, the VHM utilizes the timing properties of the heart to obtain a macro-level view by lumping cells into node and path automaton.
The heart can be represented as a conduction network ( Fig. 2(b) ), because a piece of activated heart tissue can only activate its neighboring tissue. On a conduction path from tissue A to tissue B, a stimulus cannot reach B if A is in refractory, even if B is at rest. We can use this idea to model a section of tissue as two node automata connected by one path automaton. The refractory properties of the component are represented by the nodes and the conduction properties between the nodes are modeled by the path. We can represent different structures of the heart by varying the parameters of the nodes and paths.
The basic state transitions of the node automaton and the path automaton are shown in Fig. 3(b) and Fig. 3(c) . In node automaton, the refractoriness is modeled as ERP, RRP and Rest states. In path automaton, the conduction properties are modeled as no conduction (Idle), antegrade or forward conduction (Ante), retrograde or backward conduction (Retro), conduction in both directions (Double), and conflict (Conflict) state. Each state has an internal timer T state , and the paths have conduction velocity V state . The default refractory and conduction parameters are tuned in relation to the true refractory periods measured in clinical electrophysiology studies [12] . These allow us to produce clinically-relevant results.
It has been studied in [13] and [14] that action potential duration is dependent on the timing of stimuli. We made an exponential approximation of the trend to create similar behavior. In addition, the portion of total refractory period that is unexcitable is dependent on the amplitude of the stimuli [15] . For simplification, we assume a fixed amplitude for all stimuli, which is the case in most implantable devices.
For the node automata in our model, the default value of its T erp timer is determined by the earliness of a stimulus when it is applied to the node. The earliness C early has value 0-1, which is a measurement of how early the stimulus is applied to the node before Rest state (Eq. 1). Eq. 3 shows how T erp depends on the earliness of a stimuli. For nodes in the atria, His-Purkinje system, and ventricles, when the earliness increases, the default value of T erp decreases, similar to the result in [14] . The AV node has an opposite trend where T erp increases when the earliness increases, matching the result in [12] .
The earliness of the stimulus also determines the conduction delay (T ante and T retro ) of its neighboring paths. The equations for forward and backward conduction delay are shown in Eq. 5 and Eq. 6 respectively. For all heart tissues, the conduction delay increases as the earliness increases. For the AV node the relationship is linear, which increase faster than for other tissues.
where C rrp is the ratio between current RRP timer value of the i th node and its default value when the node is activated.
where T min erp and T max erp are minimum and maximum values of the default value of T erp .
where ante del = path length/V ante .
where retro del = path length/V retro . The state transitions of node automaton and path automaton are shown below: neighboring paths and change the T ante or T retro (Eq. 5-6).
• In ERP state: calculate T erp (Eq. 3), neighboring paths are not activated.
• In RRP state: go to ERP state, activate neighboring paths, calculate T erp (Eq. 3), and change the conduction velocity of neighboring paths (Eq. 5-6).
-When no activation signal is received at node
• In Rest state: SA and AV nodes count down the Rest timer, when the timer times out, activate itself, go to ERP state, activate neighboring paths and change the conduction speed of neighboring paths according to Eq. 5-6. Other nodes stay in Rest state.
• In ERP state: count down ERP timer and go to RRP state after the timer runs out.
• In RRP state: count down RRP timer and go to Rest state after the timer runs out.
Path automata state transitions:
The path automata is initially Idle until either of the nodes it connects to is activated (Act 1 or Act 2). The path starts the antegrade or retrograde conduction timer according to which node is activated. After T ante or T retro times out, the path activates the node at the opposite end. Because this node activates all paths it is connected to, the path where the activation originated goes to Conflict state to prevent back conduction. If a path is already in antegrade conduction when a second activation signal enters from the opposite end, the path enters the Double state. Both T ante and T retro count down until the timers correspond to the same location in space and the path goes to the Conflict state.
C. . Functional and Formal VHM interface
Our platform provides two interfaces, a formal signal for interfacing with medical device software and a functional electrogram for real device implementation (see Fig. 1 ). We introduce probes into the model which mimic sensing from electrodes in catheters or pacemaker leads. These probes generate synthetic unipolar electrograms by multiplying activations on neighboring paths by a distance-dependent Gaussian factor and summing them together. The bipolar electrograms are calculated as the differences between two unipolar signals. The bipolar formal signal is generated using an AND operation between the two unipolar formal signals. Fig. 4(a) , Fig. 4(b) and Fig. 4(c) demonstrate how varying the location of the probe pair and the conduction delay of the path can causes changes in electrogram morphology. The formal signal is useful for interacting with medical device software running at a lower frequency than the VHM. 
D. . Simulink Implementation of the VHM
The general automata and probe set used in our simulations is shown if Fig. 2(b) . The probes are placed in specific areas to capture key activation timing intervals in the heart. Fig. 5 shows the simulation GUI developed in Matlab, where the automata network is superimposed on the heart anatomy. The length of paths are measured in pixels to provide a relative length relationship between different heart structures. Users can track the updated values of timers on the right side tables. Users can view electrograms and deliver programmed pacing in realtime. Fig. 6 shows the electrograms measured from the probes in the model. The underlying node automata and path automata are implemented in Simulink, as shown in Fig. 7 and Fig. 8 . Simulink was chosen because both the functional and formal models could be developed from a common kernel.
III. . MEDICAL VALIDATION OF VHM
In order to validate the function of the heart model, we compare the behavior of the VHM to common arrhythmias seen in real patients. The same classical electrophysiology techniques used on patients were used on the VHM. These include a stimulus drive train, pacing at a constant cycle length (rate), and extrastimuli, introducing an early pace stimulus faster than the drive train. The clinical relevance of the electrogram outputs from the model has been validated by an electrophysiologist. In the following cases, we illustrate how our model can reproduce the underlying electrical activity of the cardiac phenomenon. While these cases may seem rather detailed to the real-time community they capture the fundamental behavior of the node and path automatas through failures in impulse generation and propagation.
A. . Case 1: Conduction Response to Atrial Extrastimuli
The most basic electrophysiological test uses atrial extrastimuli to locate abnormalities in the heart's conduction system. This case highlights the capability of our model to simulate conduction delays.
Atrial extrastimuli testing is used to characterize different sites of conduction delay and block in the heart. After a drive train is delivered, an extrastimulus is introduced to test conduction velocity. The time between the last (a) Response in a patient [12] , with BCL 800 msec. (b) Response in the heart model, with BCL 700 msec. drive train stimulus and the extrastimulus is the coupling interval A 1 − A 2 . For long coupling intervals, there is no apparent delay. When the coupling interval is short enough to fall on the RRP of the delayed node, it causes delays downstream. The most common delays are seen in the AV node because total refractory period of the AV node is longer than that of any other node group ( Fig. 9(a) ). By setting the refractory period parameters so that the AV node has the longest total refractory period, as shown in Table I , the heart model can generate similar trends, depicted in Fig. 9(b) .
B. . Case 2: Wenckebach-type A-V nodal response
This case illustrates Wenckebach block, where conduction through the AV node slows, causing the ERP to lengthen [16] . This results in a dropped beat due to failure of propagation from the atria to ventricles. This case highlights the capability of VHM to mimic the behavior of the AV node.
Electrophysiologists use an atrial drive train to induce a Wenckebach block. At shorter cycle lengths, the AV conduction delay increases after each pacing stimulus until there is a dropped beat in the ventricles (as shown in Fig. 10 ). This phenomena occurs because the ERP lengthens each time a stimulus arrives at the AV node during RRP. When the ERP becomes longer than the cycle length, the stimulus arrives during ERP and conduction is blocked (as shown in Fig. 11 ). 
C. . Case 3: AV Nodal Reentry Tachycardia
Tachyarrhythmias are the cause of significant mortality. The most common mechanism for these arrhythmias is a reentry circuit. This case uses AV nodal reentry tachycardia (AVNRT) to demonstrate the capability of our model to produce abnormal heart behaviors. It captures the conduction properties of paths and the refractoriness of nodes.
AVNRT can occur in patients of all ages due to premature depolarizations in the atria. In these patients, there is an extra path with slow conduction and short refractory period in the AV node in addition to the normal fast path with long refractory period, creating a circuit (Fig. 13) . At normal rates, conduction cannot occur through this slow path. However, when the atria are activated early by an extrastimuli, as in Fig. 13 , AVNRT can be induced. The simulation results from our heart model are shown in Fig. 12 . In this study we specifically focus on the artificial pacemaker device (hence forth referred to as pacemaker). The pacemaker was selected as it is relatively simple, has been widely used for a number of decades, and yet has been subject to a large number of recalls. We designed and validated the functional pacemaker model using the two most frequently seen arrhythmias. The formal model of the pacemaker was designed and verified within the context of the VHM using Simulink Design Verifier [10] (Fig. 14) . The results are applicable only to the cases investigated and further results may be found in the technical report [17] .
A. . Artificial Pacemaker
Some background is provided in order to better understand the need and the operation of the pacemaker. Rhythm management from a cardiac pacemaker is a necessary therapy for patients with brady and tachyarrhythmias. The pacemaker leads are implanted inside the patient's heart in the wall of the atrium, ventricle, or both chambers of the heart. Electrodes on the lead can have both sensing and pacing abilities, depending on the mode in which the pacemaker is operating. The Heart Rhythm Society has developed a five-position code to describe the modality of the pacemaker [18] , though the first three positions contain the most pertinent information. Position I describes the pacing locations, position II describes the sensing locations, and position III describes how the device responds to sensing. The physician chooses the pacemaker mode based on the location and nature of the patient's specific arrhythmias.
B. . Pacemaker model
The pacemaker model has the capability to operate in any mode, but specifically the AAI and DDD modes have been implemented and tested with our heart model. AAI is single chamber mode that provides demand pacing from an atrium lead. If an intrinsic event is sensed by the lead, the pacing function is inhibited; otherwise, it will pace the chamber. This mode cannot ensure synchrony between the atrial and ventricular rhythms, which can be problematic and lead to pacemaker syndrome and inefficient pumping. DDD is a more sophisticated mode of operation and is implemented in dual chamber pacemakers. The device can both sense and pace from the atrium and the ventricle, which allows for synchronous pacing and proper hemodynamics. The 5 basic timing cycles of the DDD mode pacemaker are shown in Fig. 15(b) [19] . In our pacemaker model, we designed 5 corresponding software components, shown in Fig. 15(a) . These components run in parallel and are triggered by events. We group the components as follows:
1. Lowest Rate Interval (LRI) is the most basic timing cycle and it is the only timing cycle in the AAI mode. This component keeps the heart rate above a minimum value. The LRI timer is reset after there is a sensed cardiac event. If no event has been sensed before the timer runs out, the pacemaker will deliver pacing signal.
2. Atrio-Ventricular Interval (AVI) component only appears in dual chamber modes. This component mimics the intrinsic AV delay to synchronize the atria and ventricle events. The timer is started by an atrial event. If no ventricular event is sensed before time runs out, the ventricle is paced. 
C. . Pacemaker Functional Model Validation
By simulating clinical cases using our heart model where pacemaker therapy is needed using and comparing the effects of using different modes of pacemakers, we demonstrate how our model can be used to validate pacemaker design and help physicians to determine an appropriate pacemaker mode. The following cases are common arrhythmias and are considered clinically-relevant by an electrophysiologist.
1) . Case 1: Sinus Bradycardia: This is the most basic arrhythmia that can be controlled by a pacemaker, where the patient's SA node fires at a rate less than 60 beats per minute. Fig. 16 shows the heart model simulating a bradycardia event. The T rest interval of the SA node lengthens, causing bradycardia. When the AAI pacemaker model interacts with the bradycardia heart model, the device intervenes during bradycardia and delivers pacing to the atrium (Fig. 17) . This pacing signal is conducted throughout the heart and triggers a ventricular event, 2) . Case 2: Sinus Bradycardia with Second Degree Heart Block (Wenckebach type): A patient with both bradycardia and abnormal A-V conduction system was simulated in Fig. 18 . The mechanism of this kind of heart block was shown in Section III. The electrogram in Fig. 19 shows gradually increased AV delay due to fast atrial pacing until there is a dropped beat. A DDD mode pacemaker is shown to maintain a steady ventricular rate (Fig. 20) and prevent the dropped beat.
In this subsection we validated our pacemaker model with two most common arrhythmias requiring the assistance of a pacemaker. We also showed that the heart model can be used as a tool to assist cardiologists in selecting appropriate mode.
D. . Formal Verification
The major benefit of the VHM is that the exposure of the formal interface allows use of the formal methods for verification of closed-loop designs. Several verification tools are available that can be used to check the structure and safety properties of the basic node and path units along with the test cases generated.
Simulink Design Verifier (SDV) [10] exploits a Prover technology-based formal method proving engine. To prove a property using SDV, we created a Simulink sub-system 1 This is used to verify that the pacemaker in DDD mode will keep the interval between two consecutive ventricular beats in the range [0.9s, 1.1s] range (since in the pacemaker is modeled to work with 1ms clock). However, for more complex designs, where a large number of node and path automatas are instantiated in the heart model, the Design Verifier was not able to converge.
UPPAAL [20] is a widely used tool for system verification, where properties must be expressed using temporal logic formulas before they are checked. In order to use UPPAAL the kernel of the VHM along with its formal interface have to be exported from Stateflow to UPPAAL. However, the design of node and path automatas from Fig. 7 and Fig. 8 utilizes local counters in each state which, although convenient for extraction of a VHDL description, is not very suitable for translation to UPPAAL. Thus, the first step is to redesign node and path automatas to use temporal logic supported by Stateflow in order to allow straightforward extraction of UPPAAL compliant model description. This will be an avenue for future work.
V. . PHYSICAL IMPLEMENTATION
The VHM was implemented on Xilinx Spartan-3, XC3S1000 FPGA [21] . The automatas described in Section II were designed to work with a 10MHz clock. The transition from Simulink/Stateflow design to VHDL description was done manually, although appropriate tools exist that can automatically extract VHDL code from Stateflow design ( [22] , [23] ). Since manual migration from Simulink to VHDL can be a cause of discrepancy between two designs, the use of automatic translators should be a part of future VHM models. In order to demonstrate how the VHM model can be used for closed-loop black-box testing of implantable medical devices, we used a setup shown in Fig. 22 . The pacemaker model was implemented on a FireFly sensor node [24] . The nodes run the nano-RK [25] , real-time operating system developed with timeliness as a first-class concern. Nano-RK operates with a 1ms OS tick.
The pacemaker was implemented on a FireFly node using five tasks corresponding to the automatas from Fig. 15(a) : ventricle-pace (LRI task), ventriclesense (AVI task), atrial-pace (ARP task), atrial-sense (VRP task) and a coordinator between the atrium and ventricle leads (URI task). Each task was assigned a period of 10ms . The priorities for the tasks (along with equal offsets) are assigned to match the execution order of the parallel states from Fig. 15(a) (lower value has greater priority). This implementation, while not fully reflective of the complexity of a modern pacemaker, is simple and allows the evaluator to easily disable some of the tasks to test pacemakers in any of the modes. In our initial setup of the implementation, we were able to experimentally validate the closed-loop behavior of the system in hardware. VI. . RELATED WORK Researchers have tackled the problem of heart modeling using a variety of different methods. Modern techniques are capable of producing high-resolution models down to the molecular level. Beaumont [7] modeled the activity of single ion channels in order to get a detailed description of a single cell, but creating a full model of the heart based on such details is not computationally possible in real time. Harrild [8] designed a three dimensional finite element mesh model with resolution close to the cellular level, but they were also unable to extend their model to the entire heart. In order to accommodate the memory and time constraints presented by current computing tools, empirical models that simplify the heart tissue are the best solution to allow for full heart modeling [6] . Adam [9] analyzed the wavefront of depolarization within his cardiac model, but was unable to recreate the repolarization front, and thus could not produce reentry circuits and arrhythmias. None of the previous models interface with medical devices for validation and verification.
Formal methods have traditionally been used for verification of time-critical and safety-critical embedded systems [26] . Until recently, these methods have not been used for medical device certification. The authors in [27] presented the use of Extended Finite State Machines for model checking of a resuscitation device. Formal techniques have also been applied to improve medical device protocols ( [28] ) and safety ( [29] ), but the authors either used a simplified patient model or did not model the patient at all. VII. . CONCLUSION The design of bug-free medical device software is a primary challenge in life-critical real-time systems. While implantable cardiac devices are being inserted into millions of patients worldwide, the number of recalls due to firmware problems are significant and growing in frequency. There is an urgent need for methodologies for medical device certification within the context of the biological environment. We presented an integrated approach for medical device software validation and verification with a focus on artificial cardiac pacemakers. To this effect, a real-time Virtual Heart Model was developed to model the electrophysiological operation of the human heart and interface both functionally and formally with a pacemaker model. This approach has potential to help expedite medical device certification for safer operation. The VHM also allows for exploratory electrophysiology studies for physicians to evaluate their diagnosis and determine the appropriate device therapy. The VHM is available as a free and open source platform to the research community.
